Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |  Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 2033Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
Perspectives in Clinical Research

Submit your manuscripts

  • Online submission
  • Wider visibility though open access
  • Higher impact with wider visibility
  • Prompt review

Submit article online



July-September 2019 | Vol 10 | Issue  3 Table ofContents RSS Feed
New clinical trial rules: Academic trials and tribulations
Arun Bhatt
Academic trials or investigator-initiated studies (IIS) are clinical studies conceived, planned, and managed by individual physician–researchers or an institution or a group of collaborative cli...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
Does India need more medical scientists?
Suhasini Sharma
Research in any field builds new knowledge, brings about improvements in existing practices and new advances. Biomedical research is critical for advancing the health of a nation. Sadly, in India, med...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
Review Article
Indian Council of Medical Research's National Ethical Guidelines for biomedical and health research involving human participants: The way forward from 2006 to 2017
Sapan Kumar Behera, Saibal Das, Alphienes Stanley Xavier, Sandhiya Selvarajan, Nishanthi Anandabaskar
The Indian Council of Medical Research (ICMR) recently published the third revised guidelines “National Ethical Guidelines for Biomedical and Health-Related Research Involving Human Participants...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
Original Article
Assessing knowledge, attitude, and practices of health-care providers toward pharmacovigilance and adverse drug reaction reporting at a comprehensive cancer center in Jordan
Abeer Ahmad Al Rabayah, Esra'a Mahmoud Hanoun, Ruba Hab Al Rumman
Background and Objective: Cancer patients are more likely to experience adverse drug reactions (ADRs) than other patients, because of both the complexity of the treatment regimens and the sever...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]

Read more articles....